Angiopoietin-like protein 3: a novel potential biomarker for nephrotic syndrome in children.
angiopoietin-like protein 3
biomarker
children
nephrotic syndrome
proteinuria
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2023
2023
Historique:
received:
01
12
2022
accepted:
03
05
2023
medline:
2
6
2023
pubmed:
2
6
2023
entrez:
2
6
2023
Statut:
epublish
Résumé
Angiopoietin-like 3 (ANGPTL3) is a secretory glycoprotein. It has been demonstrated that ANGPTL3 level was upregulated in minimal change nephrotic syndrome (MCNS) kidney tissues. Subsequently, our group found that ANGPTL3 level was closely correlated with nephropathy A total of 200 NS patients and 80 healthy controls (age, 1-18 years) were admitted to our institution between 2021 and 2022. The etiology of NS included primary nephrotic syndrome (PNS, Serum ANGPTL3 and urinary ANGPTL3/Cre were remarkably elevated in NS patients compared with those in healthy controls. Furthermore, serum ANGPTL3 and urinary ANGPTL3/Cre were significantly correlated with proteinuria level. Additionally, multivariate linear regression analysis demonstrated that serum ALB was independently correlated with serum ANGPTL3 and PRO/CR was independently correlated with urinary ANGPTL3/Cre in NS patients. Serum ANGPTL3 and urinary ANGPTL3/Cre showed a promising performance in the diagnosis of NS, and served as novel potential noninvasive biomarkers to assess disease severity of NS. Further exploration of the role of ANGPTL3 level may shed a new light on the treatment of NS.
Sections du résumé
Background
UNASSIGNED
Angiopoietin-like 3 (ANGPTL3) is a secretory glycoprotein. It has been demonstrated that ANGPTL3 level was upregulated in minimal change nephrotic syndrome (MCNS) kidney tissues. Subsequently, our group found that ANGPTL3 level was closely correlated with nephropathy
Methods
UNASSIGNED
A total of 200 NS patients and 80 healthy controls (age, 1-18 years) were admitted to our institution between 2021 and 2022. The etiology of NS included primary nephrotic syndrome (PNS,
Results
UNASSIGNED
Serum ANGPTL3 and urinary ANGPTL3/Cre were remarkably elevated in NS patients compared with those in healthy controls. Furthermore, serum ANGPTL3 and urinary ANGPTL3/Cre were significantly correlated with proteinuria level. Additionally, multivariate linear regression analysis demonstrated that serum ALB was independently correlated with serum ANGPTL3 and PRO/CR was independently correlated with urinary ANGPTL3/Cre in NS patients.
Conclusion
UNASSIGNED
Serum ANGPTL3 and urinary ANGPTL3/Cre showed a promising performance in the diagnosis of NS, and served as novel potential noninvasive biomarkers to assess disease severity of NS. Further exploration of the role of ANGPTL3 level may shed a new light on the treatment of NS.
Identifiants
pubmed: 37266537
doi: 10.3389/fped.2023.1113484
pmc: PMC10229790
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1113484Informations de copyright
© 2023 Wen, Liu, Dai, Hong, Ji, Liu, Zhang, Han, Lv, Liu, Shen and Xu.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Curr Atheroscler Rep. 2021 Mar 10;23(5):20
pubmed: 33694000
J Drug Target. 2019 Sep;27(8):876-884
pubmed: 30615486
N Engl J Med. 2020 Dec 10;383(24):2385-2386
pubmed: 33296565
Curr Opin Pediatr. 1999 Apr;11(2):158-61
pubmed: 10202626
Genomics. 1999 Dec 15;62(3):477-82
pubmed: 10644446
Cancer Med. 2015 May;4(5):759-69
pubmed: 25644496
Curr Med Chem. 2020;27(31):5159-5174
pubmed: 31223079
Eur Heart J. 2020 Oct 21;41(40):3946-3948
pubmed: 33170930
Pediatr Res. 2015 Jun;77(6):732-9
pubmed: 25710887
Nephrology (Carlton). 2007 Dec;12 Suppl 3:S15-20
pubmed: 17995522
Biomed Res Int. 2013;2013:135608
pubmed: 24294595
J Am Coll Cardiol. 2021 Jul 13;78(2):193-195
pubmed: 34238441
Biochem Biophys Res Commun. 2010 Aug 13;399(1):31-6
pubmed: 20633534
Lancet. 2003 Aug 23;362(9384):629-39
pubmed: 12944064
N Engl J Med. 2017 Jul 20;377(3):211-221
pubmed: 28538136
Circ Genom Precis Med. 2021 Jun;14(3):e003232
pubmed: 33887960
Int Immunopharmacol. 2022 Apr;105:108549
pubmed: 35086056
BMC Nephrol. 2019 May 24;20(1):185
pubmed: 31126248
N Engl J Med. 2020 Dec 10;383(24):2307-2319
pubmed: 33196153
Int J Mol Sci. 2021 Jul 07;22(14):
pubmed: 34298929
Acta Biochim Biophys Sin (Shanghai). 2008 Jun;40(6):459-65
pubmed: 18535744
Clin J Am Soc Nephrol. 2017 Jun 7;12(6):912-920
pubmed: 28546440
Bioengineered. 2022 Feb;13(2):2971-2980
pubmed: 35038961
Pediatr Clin North Am. 2019 Feb;66(1):73-85
pubmed: 30454752
Cell Death Dis. 2022 Oct 13;13(10):867
pubmed: 36229446
Circulation. 2019 Aug 6;140(6):470-486
pubmed: 31242752
Lipids Health Dis. 2022 Apr 10;21(1):38
pubmed: 35399079
Nat Genet. 2000 Apr;24(4):333-5
pubmed: 10742089
Biochem Biophys Res Commun. 2019 Aug 27;516(3):812-818
pubmed: 31256934
BMC Nephrol. 2015 Mar 29;16:38
pubmed: 25884163
Nat Rev Cardiol. 2020 Nov;17(11):678
pubmed: 32855535
Nat Rev Nephrol. 2011 Nov 01;8(1):52-6
pubmed: 22045242
N Engl J Med. 2017 Jul 20;377(3):222-232
pubmed: 28538111